DrugPatentWatch Database Preview
XYLOCAINE 1.5% W/ DEXTROSE 7.5% Drug Profile
Which patents cover Xylocaine 1.5% W/ Dextrose 7.5%, and when can generic versions of Xylocaine 1.5% W/ Dextrose 7.5% launch?
The generic ingredient in XYLOCAINE 1.5% W/ DEXTROSE 7.5% is lidocaine hydrochloride. There are twenty-nine drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the lidocaine hydrochloride profile page.
Summary for XYLOCAINE 1.5% W/ DEXTROSE 7.5%
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Bulk Api Vendors: | 42 |
| Clinical Trials: | 52 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | see details |
| DailyMed Link: | XYLOCAINE 1.5% W/ DEXTROSE 7.5% at DailyMed |
US Patents and Regulatory Information for XYLOCAINE 1.5% W/ DEXTROSE 7.5%
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fresenius Kabi Usa | XYLOCAINE 1.5% W/ DEXTROSE 7.5% | lidocaine hydrochloride | INJECTABLE;SPINAL | 016297-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
